By Matt Lamers
Canadian medical marijuana companies are starting to tap debt markets in a big way to fund their explosive growth, which until earlier this year had been financed almost entirely through stock offerings.
Cannabis companies raised $165.9 million via debt instruments – including convertible bonds, debentures and term loans – through August.





